Shukra Pharmaceuticals Limited

BSE:524632 Stock Report

Market Cap: ₹2.6b

Shukra Pharmaceuticals Valuation

Is 524632 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 524632 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 524632 (₹58.9) is trading above our estimate of fair value (₹48.02)

Significantly Below Fair Value: 524632 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 524632?

Key metric: As 524632 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 524632. This is calculated by dividing 524632's market cap by their current earnings.
What is 524632's PE Ratio?
PE Ratio17.9x
Earnings₹144.32m
Market Cap₹2.58b

Price to Earnings Ratio vs Peers

How does 524632's PE Ratio compare to its peers?

The above table shows the PE ratio for 524632 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average27x
524202 Lactose (India)
23xn/a₹2.1b
539730 Fredun Pharmaceuticals
17.9xn/a₹3.2b
531569 Sanjivani Paranteral
48.9xn/a₹3.4b
531726 Panchsheel Organics
18.2xn/a₹2.6b
524632 Shukra Pharmaceuticals
17.9xn/a₹2.6b

Price-To-Earnings vs Peers: 524632 is good value based on its Price-To-Earnings Ratio (17.9x) compared to the peer average (27x).


Price to Earnings Ratio vs Industry

How does 524632's PE Ratio compare vs other companies in the IN Pharmaceuticals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
INDSWFTLAB Ind-Swift Laboratories
1.6xn/aUS$70.43m
524652 Ind-Swift
2xn/aUS$13.12m
No more companies available in this PE range
524632 17.9xIndustry Avg. 31.7xNo. of Companies18PE020406080100+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 524632 is good value based on its Price-To-Earnings Ratio (17.9x) compared to the Indian Pharmaceuticals industry average (31.6x).


Price to Earnings Ratio vs Fair Ratio

What is 524632's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

524632 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio17.9x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 524632's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies